1-18 of 18
neurosecretory systems
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Combination of Nilotinib + Pegylated IFN Alpha 2a Provides Somewhat Higher Cumulative Incidence Rates of MR4.5 at M36 Versus Nilotinib Alone in Newly Diagnosed CP CML Patients. Updated Results of the Petals Phase III National Study.

Franck E Nicolini, MD PhD, Gabriel Etienne, MD PhD, Francoise Huguet, MD, Agnès Guerci-Bresler, MD PhD, Aude Charbonnier, MD PhD, Martine Escoffre-Barbe, MD, Viviane Dubruille, MD, Hyacinthe Johnson-Ansah, MD, Laurence Legros, MD PhD, Valerie Coiteux, MD, Pascale Cony-Makhoul, MD, Pascal Lenain, MD, Lydia Roy, MD, Philippe Rousselot, MD PhD, Denis Guyotat, MD PhD, Jean-Christophe Ianotto, MD PhD, Martine Gardembas, MD, Eric Deconinck, MD PhD, Fabrice Larosa, MD, Denis Caillot, MD, Pascal Turlure, MD, Stephane Courby, MD, Philippe Quittet, MD, Eric Hermet, MD, Shanti Ame, MD, Simona Lapusan, MD, Alexandre Deloire, CRA, Stephane Morisset, BioStat, Madeleine Etienne, CRA, Delphine Rea, MD, Stephanie Dulucq, PharmD, PhD, Francois-Xavier Mahon, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 494.
https://doi.org/10.1182/blood-2019-123674
Published: 2019
Journal Articles

Pre-Conditioning Serum Leptin Levels Predict Early Relapse Rates of High Risk AML after Allogeneic Stem Cell Transplantation

Mark-Alexander Schwarzbich, MD, Hao Dai, Lambros Kordelas, MD, Dietrich W. Beelen, Aleksandar Radujkovic, MD, Carsten Müller-Tidow, MD, Peter Dreger, MD, Thomas Luft, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3419.
https://doi.org/10.1182/blood-2018-99-112807
Published: 2018
Journal Articles

Liver Biopsy in Patients with Chronic Lymphocytic Leukemia: Indications and Pathological Findings

Paul J. Hampel, MD, Rebecca L King, MD, Curtis A. Hanson, MD, Douglas Simonetto, MD, Kari G. Chaffee, MS, Timothy G. Call, MD, Wei Ding, MD PhD, Saad S Kenderian, MD, Susan L. Slager, PhD, Neil E. Kay, MD, Tait D. Shanafelt, MD, Sameer A. Parikh, MD
Journal: Blood
Blood (2016) 128 (22): 5592.
https://doi.org/10.1182/blood.V128.22.5592.5592
Published: 2016
Journal Articles

Phenotypic and Transcriptional Characterization of Non-Hodgkin Lymphomas from Malawi Defines Targetable Disease Subsets

Elizabeth A. Morgan, MD, M. Patrick Sweeney, Tamiwe Tomoka, MD, Nadja Kopp, M.S., Robert A Redd, MS, Christopher Daniel Carey, MD,, Leo Masamba, MD, Steve Kamiza, MD, Geraldine S Pinkus, MD, Donna S. Neuberg, Sc.D., Scott J. Rodig, MD, PhD, Danny A. Milner, Jr., MD, M.Sc., David M. Weinstock, MD
Journal: Blood
Blood (2015) 126 (23): 2655.
https://doi.org/10.1182/blood.V126.23.2655.2655
Published: 2015
Journal Articles

Hemodynamic, Functional and Structural Markers of Vascular Involvement in Primary Systemic Light Chain (AL) Amyloidosis

Kimon Stamatelopoulos, Marita Lyka, Christos Papamichail, Maria Roussou, Maria Gavriatopoulou, Constantinos Pamboucas, Evangelos Terpos, Meletios A. Dimopoulos, Efstathios Kastritis, MD
Journal: Blood
Blood (2014) 124 (21): 2029.
https://doi.org/10.1182/blood.V124.21.2029.2029
Published: 2014
Journal Articles

Neuroendocrine Regulation Of The IL-27-Dependent Immune Response In Macrophages

Markus Bosmann, MD, Julian Roewe, Dennis Riehl, Matthias Theobald, MD, PhD, Peter A. Ward, MD
Journal: Blood
Blood (2013) 122 (21): 3460.
https://doi.org/10.1182/blood.V122.21.3460.3460
Published: 2013
Journal Articles

A Phase II Trial Of Bortezomib-Rituximab Followed By Autologous Stem Cell Harvest (SCH) and Cladribine-Cyclophosphamide-Rituximab (2CdA-Cy-Rit) Consolidation As Primary Therapy Of Waldenström's Macroglobulinemia (WM)

Sheeba K. Thomas, M.D., Tamara M Haygood, M.D., Muzaffar H. Qazilbash, MD, A. Georgina Melendez, M.D., Roxana Galvis, Kay B Delasalle, B.S., Lei Feng, M.S., Tiffany A. Richards, M.S., Felipe Samaniego, M.D., M.P.H, Luhua Wang, M.D., Jatin J. Shah, M.D., Robert Z. Orlowski, M.D., Ph.D., Donna M. Weber, M.D.
Journal: Blood
Blood (2013) 122 (21): 4396.
https://doi.org/10.1182/blood.V122.21.4396.4396
Published: 2013
Journal Articles

Other Cancers in Patients with Chronic Lymphocytic Leukemia Requiring Therapy: Association with Prognostic Factors and Impact On Survival

Lorenzo Falchi, MD, Michael J. Keating, MD, Susan Lerner, MS, Xuemei Wang, MS, Sara S. Strom, PhD, William G. Wierda, MD, Alessandra Ferrajoli, M.D.
Journal: Blood
Blood (2012) 120 (21): 3896.
https://doi.org/10.1182/blood.V120.21.3896.3896
Published: 2012
Journal Articles

Effects of NVP-BSK805, a Novel JAK2 Inhibitor, on BCR-ABL and JAK2 V617F Positive Cell Lines

Frauke Ringel, PhD, Jaspal S Kaeda, PhD, FRCPath, Michaela Schwarz, MD, Peggy Grille, Bernd Dörken, Philipp D. le Coutre, MD
Journal: Blood
Blood (2011) 118 (21): 5002.
https://doi.org/10.1182/blood.V118.21.5002.5002
Published: 2011
Journal Articles

C-Myb Regulates Mir-101 Expression During the Early Stages of Erythropoiesis

Giselle Brito, Ningkun Li, Susan E. Shetzline, PhD
Journal: Blood
Blood (2010) 116 (21): 3876.
https://doi.org/10.1182/blood.V116.21.3876.3876
Published: 2010
Journal Articles

Treatment of Primary Granulocytic Sarcoma of the Uterine Cervix: Reports of Three Cases

Zhang Jie, Sr, physician, Meng Xiao Jian, physician, Ye Xiu Jin, Jing-Song He, He Huang, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4346.
https://doi.org/10.1182/blood.V116.21.4346.4346
Published: 2010
Journal Articles

Detection of LMO2 in Normal Human Tissues and Haematopoietic and Non-Haematopoietic Tumours by a Newly Developed Rabbit Monoclonal Antibody.

Claudio Agostinelli, Jennifer C Paterson, Rajeev Gupta, Simona Righi, Federica Sandri, Pier Paolo Piccaluga, Francesco Bacci, Elena Sabattini, Stefano A. Pileri, MD, Teresa Marafioti, MD
Journal: Blood
Blood (2009) 114 (22): 2942.
https://doi.org/10.1182/blood.V114.22.2942.2942
Published: 2009
Journal Articles

Defibrotide: Seamless Phase I/II Dose Escalation Trial (ICSRI DF#1) to Stratify the Polypharmacology of a Cell Modulator to the Polypharmacology of Multi Organ Failure: Part I, Clinical Design, and Therapeutic Results

Arsinur Oral, MD
Journal: Blood
Blood (2008) 112 (11): 4316.
https://doi.org/10.1182/blood.V112.11.4316.4316
Published: 2008
Journal Articles

Serial Plasma Concentrations of Adipocytokines during Chemotherapy in Children with Acute Lymphoblastic Leukemia

Maria M Moschovi, Georgios G Trimis, Maria M Vounatsou, Katerina K Katsibardi, Alexandra A Margeli, Andreas A Damianos, George G Chrousos, Fotini F Tzortzatou-Stathopoulou, Ioannis I Papassotiriou
Journal: Blood
Blood (2008) 112 (11): 3937.
https://doi.org/10.1182/blood.V112.11.3937.3937
Published: 2008
Journal Articles

High-Dose Chemotherapy in Small Cell Neuroendocrine Carcinoma: Favorable Long-Term Outcome for Extrapulmonary Primary Localization.

Antonia M.S. Mueller, MD, Alex Kuehnemund, MD, Monika Engelhardt, MD
Journal: Blood
Blood (2006) 108 (11): 3075.
https://doi.org/10.1182/blood.V108.11.3075.3075
Published: 2006
Journal Articles

HIV-1 Proviral Integration Is Blocked by Agonists to the VpPAC2 Neuroendocrine Receptor.

Donald R. Branch, PhD, Payman Baradar Bokaei, MSc, Darinka Sakac, MSc, Xue-Zhong Ma, MD
Journal: Blood
Blood (2005) 106 (11): 1427.
https://doi.org/10.1182/blood.V106.11.1427.1427
Published: 2005
Journal Articles

Favorable Outcomes with CHOP Therapy in Plasmablastic Lymphoma in HIV Positive Patients.

Masumeh Rafati Javidan, MD, Alpesh J. Amin, MD, Gunwant Guron, MD
Journal: Blood
Blood (2005) 106 (11): 4696.
https://doi.org/10.1182/blood.V106.11.4696.4696
Published: 2005
Journal Articles

Insulin-Like Growth Factor I Is a Positive Regulator of Thymic Function.

Yu-Waye Chu, M.D., Shoshana Yakar, Ph.D., Derek LeRoith, Ph.D., Ronald Gress, M.D.
Journal: Blood
Blood (2004) 104 (11): 732.
https://doi.org/10.1182/blood.V104.11.732.732
Published: 2004